• Latin American anaphylaxis registry 

      Jares, Edgardo J.; Cardona, Victoria; Gómez, Maximiliano; Bernstein, Jonathan A.; Rosario Filho, Nelson A.; Cherrez-Ojeda, Ivan; Ensina, Luis Felipe; De Falco, Alicia; Díaz, María C.; Chávez Vereau, Pierre A.; Rocha Felix, Mara M.; Lavrut, Jorge; Moreno Laflor, Oscar I.; Latour Staffeld, Patricia; Piraino, Pedro; Alacaraz Duarte, Perla; Ivancevich, Juan C.; Dabove, Fabian; Giavina-Bianchi, Pedro; Tinoco Moran, Iván O.; Nunes Oliviera, Fabiana A.; Monsell, Silvana; Souza, María V.; Cepeda, Alfonso M.; Slullitel, Pablo D.; Morfin-Maciel, Blanca M. (Elsevier Inc. on behalf of World Allergy Organization., 2023-01-23)
      Recent data about clinical features, triggers and management of anaphylaxis in Latin America is lacking. To provide updated and extended data on anaphylaxis in this region. An online questionnaire was used, with 67 ...
    • Learnings from real-life experience of using omalizumab for chronicurticaria in Latin America 

      Cherrez Ojeda, Iván; Maurer, Marcus; Bernstein, Jonathan A; Vanegas, Emanuel; Félix, Miguel; Ramón, Germán D.; Ensina, Luis Felipe; Larco Sousa, José Ignacio; Matos Benavides, Edgar Emilio; Cardona Villa, R.; Latour Staffeld, P.; Morfin-Maciel, Blanca María; Mori, José; Wilches C, Paul; Mata, Valeria L.; Cherrez, Annia (Elsevier, 2019-01-08)
      Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity, control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation ...